2023 Archives
 

HIV/AIDS: Meeting Unmet Needs in Treatment and Prevention

United Nations | November 6, 2023

HRSA EHE PrEP data from community health centers (excel)

HIV+HEP Policy Institute | October 19, 2023

More than a third of eligible beneficiaries on PrEP for HIV, but disparities persist

The Hill | October 17, 2023

PrEP, a Key HIV Prevention Tool, Isn’t Reaching Black Women

KFF Health news | October 12, 2023

Missed Chances for Screening in Persons Newly Diagnosed with HIV: New York City, 2018–2022

NEJM | September 26, 2023

HIV Testing Post-Pandemic: Implications to Ending the HIV Epidemic Plan 

Infectious Disease Special Edition | September 1, 2023

Perspectives on long-acting formulations of pre-exposure prophylaxis (PrEP) among men who have sex with men who are non-adherent to daily oral...

BMC Public Health. 2023 Aug 28;23(1):1643. doi: 10.1186/s12889-023-16382-4

PrEParing for the End of the HIV Epidemic—A Public Health Imperative | Guidelines 

JAMA Network | August 22, 2023

Is Higher Adherence Required for Women using Oral Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Preexposure...

Clin Infect Dis. 2023 Aug 17;ciad485. doi: 10.1093/cid/ciad485

Pre-Exposure Prophylaxis Continues to be Effective in Preventing HIV, Certain Populations ... 

Pharmacy Times | August 9, 2023

Preparing for long-acting PrEP delivery: building on lessons from oral PrEP 

J Int AIDS Soc. 2023 Jul;26 Suppl 2:e26103. doi: 10.1002/jia2.26103.

Who prefers what? Correlates of preferences for next-generation HIV prevention products among a national U.S. sample of young men who...

J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26096. doi: 10.1002/jia2.26096.

Factors Associated With Long-Term Adherence to Daily HIV PrEP Among MSM 

Infectious Disease Advisor | July 7, 2023

Breakthrough HIV-1 infection in setting of cabotegravir for HIV pre-exposure prophylaxis

NIH | PubMed | July 4, 2023

PrEP Implant That Protects Against HIV Could Be Near

USNews.com | June 29, 2023

   

Disparities in HIV Prevention: New Data Reveal Racial and Regional Gaps in PrEP Usage 

Contagion Live | June 28, 2023

AIDSVu Releases 2022 PrEP Use Data by Race/Ethnicity

AIDSVu | June 21, 2023

Urging the CDC to Recommend HIV Testing for People 65 and Older

POZ Magazine | June 20, 2023

Dried blood spot test can detect HIV and hepatitis, researchers say

Healio | April 24, 2023

PrEP for women in Europe: a systematic literature review

HIV Med. 2023 Apr 23. doi: 10.1111/hiv.13458

DoD Rolls Out Updated HIV PrEP Information 

HIV.gov | April 5, 2023

Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States...

J Int AIDS Soc. 2023 Mar;26(3):e26077. doi: 10.1002/jia2.26077.

Understanding Retention in the HIV Pre-Exposure Prophylaxis Cascade Among Cisgender Women - PubMed (nih.gov)

AIDS Patient Care STDS. 2023 Mar 24. doi: 10.1089/apc.2023.0009

Study examines parental concerns of their sexual and gender minority adolescents using PrEP 

News Medical | March 2, 2023

CDC-UNC Collaboration Yields Potential Long-term HIV Protection

UNC Health and UNC School of Medicine | February 9, 2023

Agents of change: Long-acting formulations for prevention and treatment of HIV 

MSF Access Campaign | February 2, 2023

Study Suggests Side-Effects and Costs Are Biggest Concerns for Users of HIV Pre-Exposure ... 

Newswise | January 31, 2023

Inconsistent Implementation Of The ACA’s Preventive Services Coverage Requirement Has Resulted In Differential, Unfavorable Coverage For PrEP

Health Affairs | January 26, 2023

Estimating the impact of HIV PrEP regimens containing long-acting injectable cabotegravir ... 

The Lancet | January 17, 2023

Long-acting PrEP injections could help reduce new cases of HIV in United States 

Imperial College London | January 17, 2023